Table IV.
Parameter | HR | 95% CI | P-value |
---|---|---|---|
NT-proBNP – RFO Groups: | |||
Group 1 | Reference | ||
Group 2 | 1.12 | 0.56–2.21 | 0.75 |
Group 3 | 1.34 | 0.67–2.68 | 0.40 |
Group 4 | 1.83 | 1.02–3.54 | 0.04 |
Age [years] | 1.04 | 1.02–1.06 | < 0.001 |
Diabetes (0 – no, 1 – yes) | 1.07 | 0.63–1.81 | 0.81 |
Gender (1 – male, 2 – female) | 0.76 | 0.49–1.18 | 0.76 |
Severe NYHA Class (0 – Class 1 and 2, 1 – Class 3 and 4) | 2.06 | 1.06–3.99 | 0.03 |
Hemoglobin [g/dl] | 1.21 | 1.05–1.39 | 0.01 |
Log CRP [mg/dl]* | 1.31 | 1.03–1.65 | 0.03 |
Log phosphorus [mg/dl]* | 0.82 | 0.68–0.99 | 0.04 |
Log dialysis vintage [months]* | 1.08 | 0.83–1.41 | 0.56 |
CRP – C-reactive protein, NT-proBNP – N-terminal pro-B-type natriuretic peptide, NYHA – New York Heart Association, RFO – relative fluid overload.
Hazard ratio for each increase in 1 SD in log of the variable.